Wolverine Asset Management LLC Buys Shares of 30,773 Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• Wolverine Asset Management LLC has made a new investment in Acadia Healthcare Company, purchasing 30,773 shares valued at approximately $933,000.
• Acadia Healthcare's recent earnings report showed an earnings per share of $0.83, exceeding analysts' expectations of $0.71 with revenue of $869.23 million.
• Equity research analysts have set a target price around $44.75 for Acadia Healthcare, with a consensus rating of "Moderate Buy" among multiple ratings changes.

Wolverine Asset Management LLC acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 30,773 shares of the company's stock, valued at approximately $933,000.

A number of other large investors have also recently made changes to their positions in ACHC. Quadrant Capital Group LLC grew its holdings in Acadia Healthcare by 287.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock worth $50,000 after acquiring an additional 933 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares during the last quarter. State of Wyoming acquired a new position in shares of Acadia Healthcare during the fourth quarter worth $56,000. Covestor Ltd increased its holdings in Acadia Healthcare by 27.2% in the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after buying an additional 310 shares during the last quarter. Finally, Aquatic Capital Management LLC acquired a new stake in Acadia Healthcare in the fourth quarter valued at $97,000.

Acadia Healthcare Stock Performance

Shares of ACHC stock traded down $0.25 during mid-day trading on Thursday, hitting $20.53. The stock had a trading volume of 1,579,716 shares, compared to its average volume of 2,201,698. The firm has a market cap of $1.90 billion, a PE ratio of 13.57, a PEG ratio of 3.96 and a beta of 0.88. The company's 50-day simple moving average is $22.05 and its 200-day simple moving average is $27.38. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. Acadia Healthcare Company, Inc. has a fifty-two week low of $17.13 and a fifty-two week high of $82.40.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same quarter last year, the firm earned $0.91 earnings per share. The firm's revenue was up 9.2% compared to the same quarter last year. Sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Wall Street Analyst Weigh In

ACHC has been the topic of a number of recent analyst reports. Royal Bank Of Canada set a $28.00 price objective on Acadia Healthcare and gave the company an "outperform" rating in a report on Wednesday. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Guggenheim reduced their price objective on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Mizuho set a $22.00 price objective on shares of Acadia Healthcare and gave the company a "neutral" rating in a research note on Wednesday. Finally, UBS Group decreased their price objective on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Five analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $40.77.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.